tinidazole has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aho, P; Höök-Nikanne, J; Kärkkäinen, P; Kosunen, TU; Salaspuro, M | 1 |
| Deng, N; Li, Y; Lin, H; Luo, R; Xie, L | 1 |
2 other study(ies) available for tinidazole and dinoprostone
| Article | Year |
|---|---|
The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Catechols; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gastric Mucosa; Helicobacter Infections; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentanones; Tetracycline; Tinidazole | 1996 |
Oxymatrine alleviates periodontitis in rats by inhibiting inflammatory factor secretion and regulating MMPs/TIMP protein expression1.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Dental Plaque Index; Dinoprostone; Female; Gingiva; Interleukin-1beta; Male; Matrix Metalloproteinases; Periodontitis; Quinolizines; Random Allocation; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Tinidazole; Tissue Inhibitor of Metalloproteinases; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |